Gufic Biosciences deepens global oncology push with fresh investment in Australia’s Selvax
Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology
Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology
Selvax's goal is to develop safe, effective and immunological-based treatments for a range of hard-to-treat solid tumours
Subscribe To Our Newsletter & Stay Updated